Anupam Rasayan India Ltd engages in the custom synthesis and manufacturing of specialty chemicals in India, Europe, Japan, Singapore, China, North America, and internationally. It operates through two segments: Life Science related Specialty Chemicals and Other Specialty Chemicals. The company offers life science related specialty chemicals, such as agro intermediates and agro active ingredients for the agrochemicals industry; anti-bacterial and ultraviolet protection intermediates and ingredients for the personal care industry; and intermediates and key starting materials for active pharmaceutical ingredients. It provides other specialty chemicals used in various end-user segments, including specialty pigments, specialty dyes, and polymer additives. The company was incorporated in 1984 and is headquartered in Surat, India.
Revenue projections:
Revenue projections for ANURAS Anupam Rasayan India Ltd's revenue is forecasted to dip below last year's figures, raising concerns for investors who are typically wary of declining financial performance. Such drops can directly affect the company's bottom line, potentially leading to a decrease in overall profitability, making investors more cautious in their decisions.
Financial Ratios:
currentRatio
1.423000
forwardPE
41.966408
debtToEquity
44.566000
earningsGrowth
0.447000
revenueGrowth
0.247000
grossMargins
0.579330
operatingMargins
0.227520
trailingEps
8.510000
forwardEps
21.980000
ANURAS's current ratio is 1.423, showing the company's capacity to service its short-term debt through its cash reserves and current assets. This is a positive indicator of liquidity, suggesting ANURAS has no trouble covering its short-term financial obligations. Anupam Rasayan India Ltd's positive earnings and revenue growth reflect a strong outlook for the company's business expansion. The company is expected to continue growing, with increasing profitability and sales driving further growth in the near future. With positive gross and operating margins, ANURAS demonstrates strong profitability. This reflects the company's ability to manage costs and maintain healthy profits, showcasing effective operational efficiency and financial stability. With a forward EPS greater than its trailing EPS, Anupam Rasayan India Ltd is expected to see higher profitability this year. The forecasted increase in earnings reflects optimism about the company's financial growth and potential for improved performance over the prior year.
Price projections:
Price projections for ANURAS ANURAS's price projections have gradually decreased, indicating a more conservative outlook from analysts. The repeated downward revisions suggest waning confidence in the company's ability to achieve its previous targets.
ANURAS's stock price has moved past the upper limit of projections, reflecting robust performance. However, the minimal room for further upward movement suggests that the stock may encounter resistance in maintaining its current levels.
Recommendation changes over time:
Recommendations trend for ANURAS
Analysts have developed a sell bias for Anupam Rasayan India Ltd, indicating potential caution for investors. However, it's important to base decisions on a broader set of market indicators to gain a more complete understanding of Anupam Rasayan India Ltd's future and avoid reacting solely to the analysts' negative sentiment.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
This article explores the Reserve Bank of India's initiatives aimed at enabling...
By clicking "Accept", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our tailored marketing efforts.